News and Updates

Discover how Daraxonrasib’s revolutionary resistance mapping is setting a new standard for oncology trial design, patient stratification, and survival.

When a CRO fails an FDA inspection, clinical sites face severe consequences. Learn how to protect your trial integrity and manage regulatory risks.

AbCellera’s ABCL635 hits primary endpoints in Phase 2 trials, showing significant success in treating menopause-related hot flashes. Learn more here.

Theriva Biologics reports $11.3M in cash, securing a runway for its VCN-01 oncolytic virus clinical trials for the next 3-4 quarters.

PDS Biotechnology halts its PDS0101 colorectal cancer trial to pivot toward the development of PDS0301, focusing on advanced oncology therapeutic growth.

Novartis has launched a Phase 1 clinical trial for a new drug candidate discovered via the Peptidream platform, marking a milestone in peptide-based medicine.

Explore how public health crises are often rooted in systemic policy failure. Discover why addressing social determinants is key to modern medicine.

Google researchers have unveiled AMIE, an AI system that matches physician-level accuracy and empathy in clinical consultations. Discover how it works.

Discover how Google’s AMIE AI is revolutionizing clinical consultations with expert-level diagnostic reasoning and enhanced patient communication tools.

Explore how innovative clinical trials are revolutionizing kidney disease treatment and offering new hope for patients seeking advanced renal care options.